|
|
???tair.name??? >
???browser.page.title.author???
|
"yu m l"???jsp.browse.items-by-author.description???
Showing items 201-225 of 237 (10 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2020-06-16T06:32:48Z |
2-D PSTD simulation of wave behavior analysis via optical phase conjugation phenomenon
|
Yu, M.-L.;Tseng, C.-T.;Tseng, S.H.; Yu, M.-L.; Tseng, C.-T.; Tseng, S.H.; SNOW H. TSENG |
| 臺大學術典藏 |
2020-06-16T06:32:47Z |
2-D PSTD simulation of wave behavior analysis via optical phase conjugation phenomenon
|
Yu, M.-L.;Tseng, C.-T.;Tseng, S.H.; Yu, M.-L.; Tseng, C.-T.; Tseng, S.H.; SNOW H. TSENG |
| 臺大學術典藏 |
2020-06-16T06:32:47Z |
Simulation analysis of delivering light through turbid media
|
Tseng, S.H.;Kung, T.-J.;Yu, M.-L.; Tseng, S.H.; Kung, T.-J.; Yu, M.-L.; SNOW H. TSENG |
| 臺大學術典藏 |
2020 |
2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations
|
CHEN-HUA LIU; Liu C.-J.; Peng C.-Y.; Lin H.-C.; Kao J.-H.; Chuang W.-L.; Lin C.-Y.; Hung C.-H.; Huang Y.-H.; Huang C.-F.; Hu T.-H.; Chen P.-J.; Dai C.-Y.; Yu M.-L. |
| 國立成功大學 |
2020 |
Extrahepatic Malignancy among Patients with Chronic Hepatitis C after Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)
|
Huang, C.-F.;Lai, H.-C.;Chen, Chen C.-Y.;Tseng, K.-C.;Kuo, H.-T.;Hung, C.-H.;Wang, J.-H.;Chen, J.-J.;Lee, P.-L.;Chien, R.-N.;Yang, C.-C.;Lo, G.-H.;Tai, C.-M.;Lin, C.-W.;Kao, J.-H.;Liu, C.-J.;Liu, C.-H.;Yan, S.-L.;Bair, M.-J.;Lin, C.-Y.;Su, W.-W.;Chu, Chu C.-H.;Chen, Chen C.-J.;Tung, S.-Y.;Lo, C.-C.;Cheng, P.-N.;Chiu, Y.-C.;Wang, C.-C.;Cheng, J.-S.;Tsai, W.-L.;Lin, H.-C.;Huang, Y.-H.;Yeh, M.-L.;Huang, J.-F.;Dai, C.-Y.;Chuang, W.-L.;Tsai, P.-C.;Peng, C.-Y.;Yu, M.-L. |
| 國立成功大學 |
2020 |
Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis
|
Hsu, W.-F.;Chen, Chen C.-Y.;Tseng, K.-C.;Lai, H.-C.;Kuo, H.-T.;Hung, C.-H.;Tung, S.-Y.;Wang, J.-H.;Chen, J.-J.;Lee, P.-L.;Chien, R.-N.;Lin, C.-Y.;Yang, C.-C.;Lo, G.-H.;Tai, C.-M.;Lin, C.-W.;Kao, J.-H.;Liu, C.-J.;Liu, C.-H.;Yan, S.-L.;Bair, M.-J.;Su, W.-W.;Chu, Chu C.-H.;Chen, Chen C.-J.;Lo, C.-C.;Cheng, P.-N.;Chiu, Y.-C.;Wang, C.-C.;Cheng, J.-S.;Tsai, W.-L.;Lin, H.-C.;Huang, Y.-H.;Tsai, P.-C.;Huang, J.-F.;Dai, C.-Y.;Chuang, W.-L.;Yu, M.-L.;Peng, C.-Y. |
| 國立成功大學 |
2020 |
Successful antiviral therapy reduces risk of schizophrenia among chronic hepatitis c patients: A nationwide real-world Taiwanese cohort (T-COACH)
|
Tsai, P.-C.;Chen, Chen C.-Y.;Kuo, H.-T.;Hung, C.-H.;Tseng, K.-C.;Lai, H.-C.;Peng, C.-Y.;Wang, J.-H.;Chen, J.-J.;Lee, P.-L.;Chien, R.-N.;Yang, C.-C.;Lo, G.-H.;Kao, J.-H.;Liu, C.-J.;Liu, C.-H.;Yan, S.-L.;Bair, M.-J.;Lin, C.-Y.;Su, W.-W.;Chu, Chu C.-H.;Chen, Chen C.-J.;Tung, S.-Y.;Tai, C.-M.;Lin, C.-W.;Lo, C.-C.;Cheng, P.-N.;Chiu, Y.-C.;Wang, C.-C.;Cheng, J.-S.;Tsai, W.-L.;Lin, H.-C.;Huang, Y.-H.;Yeh, M.-L.;Huang, C.-F.;Hsieh, M.-H.;Huang, J.-F.;Dai, C.-Y.;Chung, W.-L.;Ke, C.-L.K.;Yu, M.-L.;Group, T-COACH Study |
| 國立成功大學 |
2020 |
An Open-Label, Randomized, Active-Controlled Trial of 8 Versus 12 Weeks of Elbasvir/Grazoprevir for Treatment-Naive Patients with Chronic Hepatitis C Genotype 1b Infection and Mild Fibrosis (EGALITE Study): Impact of Baseline Viral Loads and NS5A Resistan
|
Huang, C.-F.;Hung, C.-H.;Cheng, P.-N.;Bair, M.-J.;Huang, Y.-H.;Kao, J.-H.;Hsu, S.-J.;Lee, P.-L.;Chen, J.-J.;Chien, R.-N.;Peng, C.-Y.;Lin, C.-Y.;Hsieh, T.-Y.;Cheng, Cheng C.-H.;Dai, C.-Y.;Huang, J.-F.;Chuang, W.-L.;Yu, M.-L. |
| 臺大學術典藏 |
2019-12-04T02:00:04Z |
Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: A randomized trial
|
Liu C.-H.;Huang C.-F.;Liu C.-J.;Dai C.-Y.;Liang C.-C.;Huang J.-F.;Hung P.-H.;Tsai H.-B.;Meng-Kun Tsai;Chen S.-I.;Lin J.-W.;Yang S.-S.;Su T.-H.;Yang H.-C.;Chen P.-J.;Chen D.-S.;Chuang W.-L.;Yu M.-L.;Kao J.-H.; Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; MENG-KUN TSAI; Chen S.-I.; Lin J.-W.; Yang S.-S.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H. |
| 國立成功大學 |
2019 |
Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study
|
Liu, C.-H.;Yu, M.-L.;Peng, C.-Y.;Hsieh, T.-Y.;Huang, Y.-H.;Su, W.-W.;Cheng, P.-N.;Lin, C.-L.;Lo, C.-C.;Chen, Chen C.-Y.;Chen, J.-J.;Ma, Q.;Brooks-Rooney, C.;Kao, J.-H. |
| 國立成功大學 |
2019 |
Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions
|
Yu, M.-L.;Hung, C.-H.;Huang, Y.-H.;Peng, C.-Y.;Lin, C.-Y.;Cheng, P.-N.;Chien, R.-N.;Hsu, S.-J.;Liu, C.-H.;Huang, C.-F.;Su, C.-W.;Huang, J.-F.;Liu, C.-J.;Kao, J.-H.;Chuang, W.-L.;Chen, P.-J.;Chen, D.-S. |
| 臺大學術典藏 |
2018-09-10T18:03:51Z |
Daclatasvir/asunaprevir/beclabuvir, all-oral, fixed-dose combination for patients with chronic hepatitis C virus genotype 1
|
Kao, J.-H.;Yu, M.-L.;Peng, C.-Y.;Heo, J.;Chu, C.-J.;Chang, T.-T.;Lee, Y.-J.;Hu, T.-H.;Yoon, K.T.;Paik, S.W.;Lim, Y.S.;Ahn, S.H.;Isakov, V.;Mcphee, F.;Hu, W.;Scott Swenson, E.;Yin, P.D.;Treitel, M.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T18:02:16Z |
Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients
|
Lee, M.-H.;Huang, C.-F.;Lai, H.-C.;Lin, C.-Y.;Dai, C.-Y.;Liu, C.-J.;Wang, J.-H.;Huang, J.-F.;Su, W.-P.;Yang, H.-C.;Kee, K.-M.;Yeh, M.-L.;Chuang, P.-H.;Hsu, S.-J.;Huang, C.-I.;Kao, J.-T.;Chen, C.-C.;Chen, S.-H.;Jeng, W.-J.;Yang, H.-I.;Yuan, Y.;Lu, S.-N.;Sheen, I.-S.;Liu, C.-H.;Peng, C.-Y.;Kao, J.-H.;Yu, M.-L.;Chuang, W.-L.;Chen, C.-J.; HUNG-CHIH YANG; CHUN-JEN LIU; CHEN-HUA LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T15:35:04Z |
APASL consensus statements and recommendation on treatment of hepatitis C
|
Omata, M.;Kanda, T.;Wei, L.;Yu, M.-L.;Chuang, W.-L.;Ibrahim, A.;Lesmana, C.R.A.;Sollano, J.;Kumar, M.;Jindal, A.;Sharma, B.C.;Hamid, S.S.;Dokmeci, A.K.;Mamun-Al-Mahtab;Mccaughan, G.W.;Wasim, J.;Crawford, D.H.G.;Kao, J.-H.;Yokosuka, O.;Lau, G.K.K.;Sarin, S.K.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T15:35:04Z |
APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing
|
Omata, M.;Kanda, T.;Wei, L.;Yu, M.-L.;Chuang, W.-L.;Ibrahim, A.;Lesmana, C.R.A.;Sollano, J.;Kumar, M.;Jindal, A.;Sharma, B.C.;Hamid, S.S.;Dokmeci, A.K.;Al-Mahtab, M.;Mccaughan, G.W.;Wasim, J.;Crawford, D.H.G.;Kao, J.-H.;Yokosuka, O.;Lau, G.K.K.;Sarin, S.K.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T09:22:23Z |
TCU: Thread compaction unit for GPGPU applications on mobile graphics hardware
|
Chen, Y.-J.; Ting, P.-S.; Yu, M.-L.; Chang, C.-M.; Chien, S.-Y.; SHAO-YI CHIEN |
| 臺大學術典藏 |
2018-09-10T08:44:32Z |
Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses
|
Yeh, M.-L.; Hung, C.-H.; Huang, J.-F.; Liu, C.-J.; Lee, C.-M.; Dai, C.-Y.; Wang, J.-H.; Lin, Z.-Y.; Lu, S.-N.; Hu, T.-H.; Yu, M.-L.; Kao, J.-H.; Chuang, W.-L.; Chen, P.-J.; Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T08:31:41Z |
Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy
|
Tseng, T.-C. ;Yu, M.-L.; Liu, C.-J.; Lin, C.-L. ;Huang, Y.-W.; Hsu, C.-S.; Liu, C.-H.; Kuo, S.F.-T. ;Pan, C.J.-H. ;Yang, S.-S. ;Su, C.-W. ;Chen, P.-J.; Chen, D.-S.; Kao, J.-H.; YI-WEN HUANG; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:24:37Z |
Chloracne, goiter, arthritis, and anemia after polychlorinated biphenyl poisoning: 14-Year follow-up of the Taiwan Yucheng cohort
|
Guo, Y.L.;Yu, M.-L.;Hsu, C.-C.;Rogan, W.J.; YUE-LIANG GUO |
| 臺大學術典藏 |
2018-09-10T07:24:35Z |
Recent trend of polychlorinated dibenzo-p-dioxins and their related compounds in the blood and sebum of Yusho and Yu-Cheng patients
|
Iida, T.;Hirakawa, H.;Matsueda, T.;Takenaka, S.;Yu, M.-L.;Guo, Y.-L.L.; YUE-LIANG GUO |
| 臺大學術典藏 |
2018-09-10T06:17:02Z |
Blood serum levels of PCBs and PCDFs in Yucheng women 14 years after exposure to a toxic rice oil
|
Guo, Y.L.;Ryan, J.J.;Lau, B.P.Y.;Yu, M.L.;Hsu, C.C.; YUE-LIANG GUO |
| 臺大學術典藏 |
2018-09-10T06:17:01Z |
Increased mortality from chronic liver disease and cirrhosis 13 years after the Taiwan 'Yucheng' ('oil disease') incident
|
Yu, M.-L.;Guo, Y.L.;Hsu, C.-C.;Rogan, W.J.; YUE-LIANG GUO |
| 臺大學術典藏 |
2018-09-10T05:46:42Z |
Cardiorespiratory function, flexibility, and body composition among geriatric Tai Chi Chuan practitioners
|
Lan, C.;Lai, J.-S.;Wong, M.-K.;Yu, M.-L.; JIN-SHIN LAI |
| 臺大學術典藏 |
2018-09-10T05:14:20Z |
Clinical trial of a combination of rice bran fiber and cholestyramine for promotion of fecal excretion of retained polychlorinated dibenzofuran and polychlorinated biphenyl in Yu-Chen patients
|
Iida, T.;Nakagawa, R.;Hirakawa, H.;Matsueda, T.;Morita, K.;Hamamura, K.;Nakayama, J.;Hori, Y.;Guo, Y.-L.L.;Chang, F.-M.;Hsiao, P.-W.;Lin, K.-C.;Yu, M.-L.;Lai, T.-J.;Chen, S.-J.;Hsu, C.-C.; YUE-LIANG GUO |
| 臺大學術典藏 |
2018-09-10T05:14:18Z |
The endocrine and reproductive function of the female Yucheng adolescents prenatally exposed to PCBs/PCDFs
|
Yang, C.-Y.;Yu, M.-L.;Guo, H.-R.;Lai, T.-J.;Hsu, C.-C.;Lambert, G.;Guo, Y.L.; YUE-LIANG GUO |
Showing items 201-225 of 237 (10 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page
|
